MIRUM PHARMACEUTICALS INC's ticker is MIRM and the CUSIP is 604749101. A total of 52 filers reported holding MIRUM PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $863,091 | +9.0% | 27,313 | -10.7% | 0.00% | 0.0% |
Q2 2023 | $791,648 | +33.7% | 30,601 | +24.1% | 0.00% | 0.0% |
Q1 2023 | $592,261 | +23.2% | 24,657 | +0.0% | 0.00% | 0.0% |
Q4 2022 | $480,714 | -5.7% | 24,652 | +1.5% | 0.00% | 0.0% |
Q3 2022 | $510,000 | +29.1% | 24,282 | +19.6% | 0.00% | 0.0% |
Q2 2022 | $395,000 | +1097.0% | 20,296 | +1244.1% | 0.00% | – |
Q1 2022 | $33,000 | +6.5% | 1,510 | -22.1% | 0.00% | – |
Q4 2021 | $31,000 | -18.4% | 1,939 | +2.1% | 0.00% | – |
Q3 2021 | $38,000 | -56.3% | 1,900 | -62.2% | 0.00% | – |
Q2 2021 | $87,000 | -49.4% | 5,025 | -42.2% | 0.00% | – |
Q1 2021 | $172,000 | +24.6% | 8,696 | +9.9% | 0.00% | – |
Q4 2020 | $138,000 | -9.8% | 7,916 | 0.0% | 0.00% | – |
Q3 2020 | $153,000 | -0.6% | 7,916 | 0.0% | 0.00% | – |
Q2 2020 | $154,000 | +38.7% | 7,916 | 0.0% | 0.00% | – |
Q1 2020 | $111,000 | +11.0% | 7,916 | +93.7% | 0.00% | – |
Q4 2019 | $100,000 | +138.1% | 4,086 | -2.5% | 0.00% | – |
Q3 2019 | $42,000 | – | 4,191 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Frazier Life Sciences Management, L.P. | 6,470,392 | $204,464,387 | 13.58% |
NEA Management Company, LLC | 2,186,243 | $69,085,279 | 5.34% |
TANG CAPITAL MANAGEMENT LLC | 1,137,107 | $35,932,581 | 5.07% |
BOONE CAPITAL MANAGEMENT LLC | 389,791 | $12,317,396 | 3.89% |
Highlander Partners, L.P. | 122,980 | $3,886,168 | 3.84% |
BVF INC/IL | 4,370,024 | $138,092,758 | 3.72% |
Prosight Management, LP | 353,508 | $11,170,853 | 3.54% |
Novo Holdings A/S | 1,500,000 | $47,400,000 | 3.50% |
Nicholas Investment Partners, LP | 1,199,366 | $37,899,966 | 2.83% |
Eventide Asset Management | 3,958,579 | $125,091,097 | 2.25% |